ARGX (argenx N.V.) Sof foyda

ARGX (argenx) - kompaniyaning tovar belgisi

argenx SE kuchli R&D investitsiyalari orqali yetakchi olimlarni jalb qilmoqda, bu esa Tim Van Hauwermeirenning malakali rahbarligi bilan birgalikda kompaniyaning asosiy dori vositasining kengayishini ta'minlaydi. Kompaniyaning umumiy sof foydasi biznesning aniq xronometri vazifasini o'taydi va joriy ko'rsatkich 1.72 ni tashkil etadi. Moliyaviy barqarorlik Yevropa va AQShda kam uchraydigan autoimmun patologiyalarning maqsadli terapiyasi uchun sug'urta kompaniyalari va davlat agentliklaridan keladigan to'lovlarga asoslangan.

ARGX (argenx SE) Sof foyda tarixi 04.07.2022dan 30.10.2026gacha

argenx (ARGX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari argenx BVBA|ARGX - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi argenx BVBA|ARGX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati argenx|ARGX - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi argenx.com|ARGX - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati argenx SE|ARGX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati argenx N.V.|ARGX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar argenx BVBA|ARGX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi argenx|Shoshilinch likvidlik argenx.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ARGX - Sof foyda
Kompaniyaning jamlanma tahlili:argenx SE
Argenx asosiy tovari

Yuqori texnologiyali biotexnologiya sektorida sof foyda barqarorligi aktivning investitsiya jozibadorligini belgilaydi. argenx SE (ARGX) kompaniyasining naqd foyda dinamikasi barcha operatsion xarajatlar chegirib tashlanganidan keyingi yakuniy moliyaviy natijani aks ettiradi. Ushbu ko'rsatkichning o'sishi, jumladan, qimmatbaho sovuq zanjir logistikasini o'z ichiga olgan xarajatlar nazoratining samaradorligini tasdiqlaydi. Trend chizig'idagi tebranishlar ta'minot zanjirlari doirasidagi xavflardan signal beradi. Barqaror yuqoriga yo'nalgan tendentsiya investorga biznesning fundamental barqarorligini kafolatlaydi.

Asosiy raqobatchilar

Sof daromad BioNTech Pharma|ABVX (Abivax S.A.) - Sof foyda|Sof foyda admabiologics.com|Sof daromad PTGX (Protagonist)|IMVT (Immunovant Inc) - Yakuniy foyda|Sof foyda KNSA (Kiniksa Pharmaceuticals Ltd)|Sof moliyaviy natija Grifols Biemat (GRFS)|ADPT - Kompaniyaning sof foydasi|celldex.com (CLDX) - Sof daromad|Aurinia Pharmaceuticals Inc. (AUPH) - Kompaniyaning sof foydasi|Sof daromad BioCryst Pharmaceuticals, Inc.|Sof daromad VERA|Sof foyda Dianthus Corp|Kompaniyaning sof foydasi Pharvaris N.V. (PHVS)|AbCellera Biologics Inc. - Kompaniya foydasi|Sof foyda TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Kompaniyaning sof daromadi|Pharming - Sof foyda|NKTR - Sof foyda|Upstream Bio Inc (UPB) - Kompaniyaning sof foydasi|zenasbio.com - Yakuniy foyda|IMNM (Immunome) - Sof foyda|GOSS - Yillik sof foyda|Sof foyda KALV|SEPN - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Pieris Pharmaceuticals PVLA|SVRA: Kompaniya foydasi|RIGL: Sof daromad|ANAB (AnaptysBio Inc) - Kompaniya foydasi|ATXS (Astria Pharma) - Sof daromad|enGene Corp - Yakuniy foyda|Kompaniyaning sof foydasi RAPT Therapeutics, Inc.|Aerovate (JBIO) - Sof moliyaviy natija|Sof foyda ACRS|KYTX - Kompaniyaning sof daromadi|Sof foyda TLSA (Tiziana Life Sciences PLC)|Sof foyda Cabaletta Bio Inc CABA|VTYX - Kompaniyaning sof foydasi|Yakuniy foyda THTX (theratech.com)|AVTX: Sof foyda|Yillik sof foyda Eledon Pharmaceuticals Inc. ELDN|Sof daromad AGEN|Kompaniya foydasi CLYM (Climb Bio, Inc)|Kompaniyaning sof foydasi Zura Bio Limited (ZURA)|ATYR: Soliqdan keyingi foyda|Sof foyda ADAG (Adagene Inc.)|Yakuniy foyda IMA|Shattuck Therapeutics - Sof foyda|EQ - Sof foyda|connectbiopharm.com (CNTB) - Kompaniyaning sof foydasi|Immunic - Yakuniy foyda|Kompaniyaning sof foydasi Atara Biotherapeutics, Inc.|Sof daromad InflaRx GmbH (IFRX)|Sof foyda XFOR|Sof foyda adicetbio.com (ACET)|Celularity - Sof daromad|Yakuniy foyda INMB|Barinthus Biotherapeutics plc - Sof foyda|Sof moliyaviy natija Kezar Life Sciences Inc. KZR|SAB Biotherapeutics, Inc (SABS) - Kompaniyaning sof foydasi|Sof daromad Akari Therapeutics, Plc|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|Sof daromad Q32 Bio Corp (QTTB)|Sof daromad GOVX (GeoVax)|Sof foyda Edesa Biotech Inc (EDSA)|Kompaniyaning sof foydasi iBio Corp IBIO|CARM: Kompaniya foydasi|XTL Biopharmaceuticals - Sof foyda|Kompaniyaning sof daromadi Bolt Biotherapeutics|HCWB: Sof foyda|Aptevo Therapeutics Inc. (APVO) - Sof foyda|Kompaniyaning sof foydasi AIM ImmunoTech|ADTX: Yakuniy foyda|Sof foyda GRI|xortx.com (XRTX) - Yillik sof foyda|Sof foyda HIND (Vyome Holdings)|Revelation Biosciences Inc (REVB) - Kompaniyaning sof daromadi|INDP - Kompaniyaning sof foydasi|SCNI (BiondVax Pharmaceuticals) - Kompaniya foydasi|CALI (calcimedica.com) - Sof daromad|Kompaniya foydasi AFMD|Sof daromad ALLK|HOOK: Yakuniy foyda|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof moliyaviy natija iTeos Pharma|Sof foyda OCEA (Ocean Biomedical, Inc.)|tcbiopharm.com (TCBP) - Kompaniyaning sof daromadi|Third Harmonic Bio, Inc. - Sof foyda